HUBB vs ORMP
Hubbell Inc (HUBB) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported HUBB revenue for 2024-12-31 was $5.63B. Net income was $783.5M. Revenue was up 4.8% from 2023-12-31 to 2024-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
HUBB currently screens at market cap $22.14B and trailing P/E 28.0. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the HUBB and ORMP stock pages for the full models.
Not investment advice.